In the last three months, 6 analysts have published ratings on IDEAYA Biosciences (NASDAQ:IDYA), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for IDEAYA Biosciences, revealing an average target of $52.33, a high estimate of $57.00, and a low estimate of $43.00. This upward trend is evident, with the current average reflecting a 29.53% increase from the previous average price target of $40.40.
Decoding Analyst Ratings: A Detailed Look
A comprehensive...
ログインすると全部閲覧できます。
ログイン